Studies have shown that in untreated OSA patients, monocytes release TGF-β to suppress NK cell function (which can be restored with CPAP treatment) (72), and IH can activate the TGF-β pathway to promote lung cancer cell migration and activation of cancer-associated fibroblasts (CAFs) (155). This evidence concerns the gene TGFB1 and obstructive sleep apnea syndrome.